TY  - JOUR 
AU  - González Salvatierra, Sheila
AU  - Martínez Heredia, Luis
AU  - Muñoz Torres, Manuel Eduardo
AU  - Riquelme Gallego, Blanca
PY  - 2021
UR  - http://hdl.handle.net/10481/68606
AB  - Osteoglycin (OGN) could be a biomarker of mild kidney function impairment in type 2 diabetes (T2D). Our study aimed to determine the association between serum OGN and impaired kidney
function risk in T2D patients and to analyze its potential role as...
LA  - eng
PB  - MDPI
KW  - Biomarker
KW  - Diabetic kidney disease
KW  - Kidney function impairment
KW  - Type 2 diabetes
KW  - Osteoglycin
TI  - Osteoglycin as a Potential Biomarker of Mild Kidney Function Impairment in Type 2 Diabetes Patients
DO  - jcm10102209
ER  -